LipoCheck secures funding from prominent investors to expand its digital health platform focused on supporting women with lipedema in Germany and beyond.

Target Information

LipoCheck, a startup based in Leipzig, focuses on addressing the often-overlooked medical condition known as lipedema, a painful fat distribution disorder. The company aims to support and guide women suffering from this condition through a digital platform that includes the LipoCheck and LipoAlly apps. These applications enable users to document their symptoms, access medical knowledge, and benefit from specialized telemedicine services.

Additionally, LipoCheck collaborates closely with health insurance companies and medical professionals to ensure comprehensive care from the initial suspicion of the condition all the way through treatment support. The founding team consists of sisters Anina Langhans and Helena Rapprich, along with their father Dr. Stefan Rapprich, whose clinical experience highlighted the medical need for such a platform.

Industry Overview

The healthcare technology industry is rapidly evolving, especially in Germany, where there is a strong emphasis on digital health solutions. The country has seen significant investments in health tech startups, drive

View Source

Similar Deals

Vorwerk Ventures Carelane

2025

Seed Stage Biotechnology & Medical Research (NEC) Germany
UVC Partners Sonia Solutions GmbH

2025

Seed Stage Healthcare Facilities & Services (NEC) Germany
LUMO Labs hema.to

2025

Seed Stage Bio Diagnostics & Testing Germany
EnjoyVenture Kynda

2025

Seed Stage Biotechnology & Medical Research (NEC) Germany
InfectoPharm AudioCure

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) Germany
TGFS Technologiegründerfonds Sachsen Medical Decision Alliance GmbH

2025

Seed Stage Hospitals, Clinics & Primary Care Services Germany

TGFS

invested in

LipoCheck

in 2025

in a Seed Stage deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert